Fast Five Quiz: Chronic Myelogenous Leukemia Management

Emmanuel C. Besa, MD


September 21, 2022

For patients with blast phase CML, induction chemotherapy in addition to a TKI is recommended, with the type of induction chemotherapy being guided by the myeloid or lymphoid lineage of the blasts. If a patient is not a candidate for induction chemotherapy, NCCN guidelines recommend a TKI; steroids may be added for patients with lymphoid blasts. A clinical trial may also be considered.

Learn more about guidelines for the management of CML.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.